<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MELAS</z:e> (<z:hpo ids='HP_0006789'>mitochondrial encephalopathy</z:hpo> with <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> and <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo>) is a maternally inherited disorder characterized by recurrent <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarctions</z:e> that do not conform to discreet vascular territories </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report on a patient who presented at 7 years of age with <z:hpo ids='HP_0007185'>loss of consciousness</z:hpo> and severe <z:hpo ids='HP_0001942'>metabolic acidosis</z:hpo> following <z:hpo ids='HP_0002013'>vomiting</z:hpo> and <z:hpo ids='HP_0001944'>dehydration</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>She developed progressive <z:mp ids='MP_0004740'>sensorineural hearing loss</z:mp>, <z:hpo ids='HP_0003198'>myopathy</z:hpo>, <z:hpo ids='HP_0000508'>ptosis</z:hpo>, <z:hpo ids='HP_0004322'>short stature</z:hpo>, and mild developmental delays after <z:mpath ids='MPATH_458'>normal</z:mpath> early development </plain></SENT>
<SENT sid="3" pm="."><plain>Biochemical testing identified metabolites characteristic of medium-chain <z:chebi fb="0" ids="17984">acyl-CoA</z:chebi> dehydrogenase (MCAD) deficiency (hexanoylglycine and suberylglycine), but also severe <z:hpo ids='HP_0003128'>lactic acidemia</z:hpo> (10-25 mM) and, in urine, excess of <z:chebi fb="22" ids="28358">lactic acid</z:chebi>, intermediates of the citric cycle, and marked <z:hpo ids='HP_0002919'>ketonuria</z:hpo>, suggesting <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction </plain></SENT>
<SENT sid="4" pm="."><plain>She progressed rapidly to develop temporary <z:hpo ids='HP_0100704'>cortical blindness</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Brain imaging indicated generalized <z:mpath ids='MPATH_127'>atrophy</z:mpath>, more marked on the left side, in addition to <z:hpo ids='HP_0002500'>white matter alterations</z:hpo> consistent with a <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorder </plain></SENT>
<SENT sid="6" pm="."><plain>Magnetic resonance angiography indicated occlusion of the left cerebral artery with development of collateral circulation (<z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya syndrome</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>This process worsened over time to involve the other side of the brain </plain></SENT>
<SENT sid="8" pm="."><plain>A muscle biopsy indicated the presence of numerous <z:hpo ids='HP_0003200'>ragged red fibers</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Molecular testing confirmed compound heterozygosity for the common mutation in the MCAD gene (985A&gt;G) and a second pathogenic mutation (233T&gt;C) </plain></SENT>
<SENT sid="10" pm="."><plain>MtDNA testing indicated that the muscle was almost homoplasmic for the 3243A&gt;T mutation in tRNALeu, with a lower mutant load (about 50% heteroplasmy) in blood and skin fibroblasts </plain></SENT>
<SENT sid="11" pm="."><plain>These results indicate that <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorders may be associated with severe <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> resulting in <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya syndrome</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The contribution of the concomitant <z:e sem="disease" ids="C0220710" disease_type="Disease or Syndrome" abbrv="">MCAD deficiency</z:e> to the development of the phenotype in this case is unclear </plain></SENT>
</text></document>